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Abstract
Background: The objective of this study is to evaluate the effectiveness of preoperative endoscopic localization
of colorectal cancer and tracing lymph nodes by carbon nanoparticle tattooing in laparoscopic colorectal
cancer surgery.
Methods: From January 2013 to December 2014, 54 patients with colorectal cancer were recruited and divided
into experimental (n = 27) and control (n = 27) groups. The patients in the experimental group were localized
preoperatively by endoscopic carbon nanoparticle tattooing, whereas patients in the control group were
not tattooed.
Results: All injection sites in the experimental group were visible to surgeons. No abdominal pain, fever,
diarrhea, and other symptoms of infection were found in the experimental group. The time for detecting the
tumor (2.71 ± 2.13 min versus 6.91 ± 5.16 min, p < 0.001), operation time (151.22 ± 30.66 min versus 170.26 ± 33.
13 min, p = 0.033), and blood loss during the operation (125.04 ± 29.48 mL versus 147.52 ± 34.35 mL, p = 0.013)
were lower in the experimental group than in the control group. Average numbers of dissected lymph nodes
in the experimental group exceeded those in the control group (14.41 ± 3.32 versus 8.96 ± 2.90, p < 0.001),
and the rate of dissected lymph nodes ≥12 was higher in the experimental group than in the control group
(70.37 versus 37.04 %, p < 0.001). Moreover, no difference in postoperative complications was found between
the two groups.
Conclusions: Tattooing colorectal cancer with carbon nanoparticles in laparoscopic colorectal cancer surgery is
safe and useful both in localization and lymph node tracing.
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Background
Colorectal cancer is the third most commonly diagnosed
cancer in males and is the second most commonly diag-
nosed cancer in females. This disease is among the main
causes of cancer death in both males and females [1]. In re-
cent years, laparoscopic operation has become increasingly
common and important for colorectal cancer surgical the-
rapy. Numerous large studies have proven that survival
and recurrence rates were comparable with those of con-
ventional surgery [2, 3]. Compared with traditional lapar-
otomy, laparoscopic colorectal resection offers numerous
advantages, such as smaller abdominal wall incision, lower
hemorrhage amount, lower postoperative complication,
and faster postoperative recovery [4, 5].
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However, colonoscopy visual localizing colorectal can-
cer is considerably affected by an operator’s subjective
experience. Thus, deviations easily appear on location
over the colorectum, particularly with small lesions and
at an early tumor stage. As the organs could only be ma-
nipulated with the use of an instrument and owing to
the lack of hand feeling during laparoscopic colorectal
cancer surgery, precise localization of the tumor by sur-
geons is difficult, especially in the absence of obvious
lesion changes or marks on the serosal surface [6].
Therefore, according to the NCCN guideline [7], pre-
operative colonoscopic localization is recommended for
small lesions in laparoscopic-assisted colectomy.
At present, numerous methods are employed for colo-
rectal cancer localization, including double contrast bar-
ium localization, titanium clip localization, intraoperative
enteroscopy localization, and preoperative injection stain
localization. Common dyes include toluidine blue, isosul-
fan blue, hematoxylin, eosin, India ink, and so on [8–10].
However, the aforementioned methods have their own
drawbacks and limitations, such as inaccurate localization,
omission of certain small lesions, poor cost performance
of clips, and colonic insufflations [10–12].
Accurate identification of the lymph node status of
colorectal cancer patients poses another challenge for
surgeons. Studies have shown that adequate number of
lymph nodes is crucial in the staging of colorectal cancer
patients [13]. The adequate number of dissected lymph
nodes is associated with improved survival rate [14, 15].
Moreover, patients with ≥12 dissected lymph nodes show
better prognosis than patients with <12 dissected lymph
nodes [16]. However, current standard procedure for lymph
node evaluation involves a single-level section of each
discovered lymph node and staining with hematoxylin–
eosin. This method can find only a small portion of the
lymph nodes, thereby implying a relevant risk of sampling
error and subsequent understaging [17]. To date, an ideal
method to address this problem is not available.
In recent years, with the development of nanotechnology,
carbon nanoparticles have been widely used for tumor
tattooing and lymph node tracing [11, 18, 19]. An injection
of carbon nanoparticle suspension comprises nanosized
carbon particles with an average diameter of 150 nm. These
particles enter the lymphatic vessels rather than the blood
vessels. Owing to their ideal effects and few side effects,
carbon nanoparticles have been used in different kinds of
surgeries for different cancers, such as breast cancer [18],
thyroid cancer [19], and colorectal cancer [11]. However,
studies that focus on laparoscopic colorectal surgery are few.
Our study used carbon nanoparticle suspension for
tattooing colorectal cancer and tracing lymph nodes.
Then, we performed laparoscopic colorectal resection and
aimed to evaluate the effectiveness of the approach in
laparoscopic colorectal surgery.
Methods
Patient selection and characteristics
We conducted a retrospective case-control study involving
54 patients who were treated in the First Affiliated Hospital
of Wenzhou Medical University between January 2013 and
December 2014. A total of 54 patients with colorectal
cancer who had undergone laparoscopic colorectal radical
resection were enrolled. All patients corresponded to the
following inclusion criteria: 18–70 years old, TNM staging
I–III, single colorectal cancer confirmed by colonoscopic
biopsy, underwent radical resection, no history of abdom-
inal surgery, and no contraindications of laparoscopic sur-
gery. Exclusion criteria included the following: distant
metastasis; underwent local excision; prior abdominal can-
cer surgery; history of other abdominal malignancies; emer-
gency case with bleeding, obstruction, or perforation; and
received chemotherapy, radiotherapy, or both prior to sur-
gery. All surgical procedures were completed by the same
team of surgeons. The surgical procedure conducted in this
study was performed according to the NCCN guideline for
colon and rectal cancers. The clinical data of patients were
obtained from their electronic medical records. TNM sta-
ging was based on the seventh edition of the American
Joint Cancer Committee TNM classification [20]. The path-
ology examination was performed independently by the
two pathologists for all samples.
This study was approved by the Ethics Committee of the
First Affiliated Hospital of Wenzhou Medical University,
and informed consent was obtained from each patient.
Drug
Carbon nanoparticles (Chongqing LUMMY Pharmaceut-
ical Co., Chongqing, China) were applied in the form of
injection of a standard carbon nanoparticle suspension
(1 mL; 50 mg). Carbon nanoparticles were in a stable
suspension of carbon pellets (150 nm in diameter). The
pellets entered the lymphatic vessels rather than the blood
vessels. No toxic side effects were observed. After several
months, the pellets could be excreted through the lungs
and intestines. To date, few relevant studies reported that
carbon nanoparticles cause any acute systemic toxicity
[10, 17, 18, 21, 22].
Preoperative localization
The patients in the experimental group were subjected to
full intestinal cleaning preparation 1 day prior to tattooing
colorectal cancer. During colonoscopy, we first found the
tumor by conventional operation procedures and injected
about 1.0-mL carbon nanoparticles into the submucosal
layer at four points around the lesion of the primary
tumor. The injection dose (1.0 mL) was referred to studies
from others [10, 21, 23]. Each patient was treated with
metronidazole tablets for antibiotic prophylaxis after col-
onoscopy. Preoperative computed tomography and general
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colonoscopy were used for localization for patients in the
control group. All patients in the experimental group
received preoperative localization at 3 to 7 days before the
operation. The endoscopic tattooing was performed by an
experienced endoscopy doctor.
Statistical method
The cutoff value of dissected lymph node number was
identified as 12 according to many published studies
[24–26]. Normal distribution data were expressed as
mean ± standard deviation (SD) and compared using t test.
Categorical variables were expressed as percentage and
compared with chi-square test or Fisher’s exact test, as
appropriate. All p values were two-sided, and a p value
of <0.05 was considered statistically significant. Statis-
tical analysis was performed with SPSS software version
19.0 (SPSS, Chicago, IL, USA).
Results
Patient demographics and cancer characteristics
The 54 patients enrolled in our study were divided into
the experimental group (n = 27; 19 males and 8 females;
mean age, 62.81 ± 11.29 years old) and the control group
(n = 27; 14 males and 13 females; mean age 64.63 ±
10.05 years old). Patient demographics and cancer charac-
teristics are summarized in Table 1. All patient demo-
graphics and cancer characteristics, including age, gender,
tumor diameter, tumor differentiation, tumor location, T
stage, N stage, Dukes stage, and clinical stage, exhibited
no statistical difference between the two groups (p > 0.05).
Clinical results of preoperative colonoscopic localization
using carbon nanoparticles
Tumors in all patients in the experimental group were
localized by preoperative colonoscopic tattooing with car-
bon nanoparticles. The time from preoperative endoscopic
localization to surgery ranged from 3 to 7 days (an average
of 5 days). One patient in the experimental group under-
went surgery following carbon nanoparticle tattooing after
1.5 months because of personal reasons. Adverse reactions,
such as abdominal pain, fever, diarrhea, infection, and other
sources of discomfort, were not observed.
In laparoscopic colorectal surgery, colorectal serosa
corresponding to the tumor location was evidently stained
black. As shown in Table 2, the time from entering the
abdominal cavity to finding the lesion was considerably
shorter in the experimental group than in the control
group, i.e., 2.71 ± 2.13 min versus 6.91 ± 5.16 min (p <
0.001). Moreover, operation time was shorter in the experi-
mental group than in the control group, i.e., 151.22 ±
30.66 min versus 170.26 ± 33.13 min (p = 0.033). Blood loss
during the operation was less in the experimental group in
comparison with the control group, i.e., 125.04 ± 29.48 mL
versus 147.52 ± 34.35 mL (p = 0.013). Furthermore, the
number of dissected lymph nodes in the experimental
group was considerably higher than in the control group,
i.e., 14.41 ± 3.32 versus 8.96 ± 2.90 (p < 0.001). The rate of
the number of dissected lymph node number ≥12 was
higher in the experimental group than in the control group,
i.e., 70.37 versus 37.04 % (p = 0.014). Rates of patients with
lymph node metastasis between two groups, i.e., 44.44
versus 25.93 % (p = 0.154) were not significantly different.
No difference was found between the two groups in terms
of postoperative complications, including bleeding, infec-
tion, anastomotic leakage, intestinal obstruction, urinary











63.72 ± 10.63 62.81 ±
11.29
64.63 ± 10.05 0.536
Gender 0.163
Male 33 19 (70.37 %) 14 (51.85 %)
Female 21 8 (29.63 %) 13 (48.15 %)
Mean tumor
diameter (cm)
4.31 ± 1.57 4.31 ± 1.67 4.31 ± 1.48 0.986
Tumor differentiation 0.738
Well 13 6 (22.22 %) 7 (25.93 %)
Moderately 33 16 (59.26 %) 17 (62.96 %)
Poorly 8 5 (18.52 %) 3 (11.11 %)
Tumor location 0.726
Transverse colon 8 4 (14.81 %) 4 (14.81 %)
Right hemicolon 14 9 (33.33 %) 5 (18.52 %)
Left hemicolon 11 5 (18.52 %) 6 (22.22 %)
Sigmoid colon 11 4 (14.81 %) 7 (25.93 %)
Rectum 10 5 (18.52 %) 5 (18.52 %)
T stage 0.775
T1 3 1 (3.70 %) 2 (7.41 %)
T2 19 9 (33.33 %) 10 (37.04 %)
T3 32 17 (62.96 %) 15 (55.56 %)
N stage 0.588
N0 37 17 (62.96 %) 20 (74.07 %)
N1 11 7 (25.93 %) 4 (14.81 %)
N2 6 3 (11.11 %) 3 (11.11 %)
Dukes stage 0.661
A 16 7 (25.93 %) 9 (33.33 %)
B 21 10 (37.04 %) 11 (40.74 %)
C 17 10 (37.04 %) 7 (25.93 %)
Clinical stage 0.475
I 17 8 (29.63 %) 9 (33.33 %)
II 21 9 (33.33 %) 12 (44.44 %)
III 16 10 (37.04 %) 6 (22.22 %)
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complication, and intractable fecal incontinence. All patients
in the experimental group fulfilled two conditions, namely,
radical resection of the lesion and negative margins on both
sides of the resected specimen. When checking the resected
specimens during surgery in the control group, we found
insufficient resection range of tumorous distal bowel in one
patient. Only additional surgery could achieve radical resec-
tion. Moreover, the time of injection was not significantly
associated with the effectiveness of the method (Table 3).
Interestingly, besides the stained black lesions that were
found during operation, several stained lymph nodes were
also found (Fig. 1). Then, postoperative pathological examin-
ation demonstrated that a part of this tracing lymph nodes
were metastatic lymph nodes (Fig. 2). In addition, since
lymph nodes were stained in black (although not all lymph
nodes) in the experimental group, they were more easily to
be dissected by pathologists compared with that in the con-
trol group (Fig. 1).
Discussion
In recent years, laparoscopic approaches had been widely
used in colorectal cancer because of lower damage, fewer
complications, and comparable survival and recurrence
rates [2–5]. However, surgeons faced two tough challenges.
The first challenge is the accurate localization of tumor pre-
operatively and intraoperatively, especially for small tumors.
The second challenge is how to examine sufficient lymph
nodes to accurately establish N staging, which is signifi-
cantly correlated with prognosis [27].
Nowadays, there are many types of localizing methods,
such as double contrast barium localization, titanium clip
localization, intraoperative enteroscopy localization, and
preoperative injection stain localization [8–10]. The omis-
sion of smaller lesions is a disadvantage of the double con-
trast barium localizing method [12]. The drawback of the
titanium clip localizing method is that titanium clips often
fall off easily after several days [10]. Moreover, as clips
cannot be seen from the serosal side, the clips are of no
value to surgeons unless special intraoperative equipment
(such as sonography or fluoroscopy) is used to identify
these clips [28]. Intraoperative enteroscopy localization
method requires specialized intraoperative enteroscopy
and accompanying endoscopists. Moreover, this step
would increase surgical time and probability of infection
[29]. Dyes including toluidine blue, isosulfan blue,
hematoxylin, eosin, and India ink had been widely used in
the localization [30–32]. Some dyes contribute to the in-
accuracy of localization, such as toluidine blue and isosul-
fan blue, because of relatively short dyeing time and easy
diffusion over time [10]. India ink has been widely used in
staining, but the ingredients could trigger inflammation in
several patients, thereby risking complications [22, 30, 33].
Table 2 Clinical results of preoperative colonoscopic










4.81 ± 4.45 2.71 ± 2.13 6.91 ± 5.16 <0.001*
Blood loss 136.28 ± 33.68 125.04 ± 29.48 147.52 ± 34.35 0.013*
Operation time 160.74 ± 33.04 151.22 ± 30.66 170.26 ± 33.13 0.033*
Dissected lymph
nodes number




≥12 29 19 (70.37 %) 10 (37.04 %)
<12 25 8 (29.63 %) 17 (62.96 %) 0.154
Lymph node
metastasis
Yes 19 12 (44.44 %) 7 (25.93 %)
No 35 15 (55.56 %) 20 (74.07 %)
Postoperative
complications
Bleeding 2 1 1














Fig. 1 Lymph nodes dyed by carbon nanoparticles. White arrow points
to stained black tumor lesions. Coarse black arrow indicates the lymph
nodes with carbon nanoparticles dyed. Thin black arrow shows the
lymphatic vessels dyed by carbon nanoparticles
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In consideration of the ideal effects and low side effects,
carbon nanoparticles have been used in different kinds of
cancer operations, like breast cancer [18], thyroid cancer
[19], and colorectal cancer [11]. At present, carbon nano-
particles have been used more widely in China [18, 19, 34].
In our study, we localized colorectal cancer and traced
lymph nodes with carbon nanoparticle suspension to evalu-
ate their effectiveness in laparoscopic colorectal resection.
In terms of tumor size, patients received subserosal injec-
tion in three to four quadrant regions by tattooing a carbon
nanoparticle suspension in a plane interval of the same
distance. Thus, the specific location of bowel is observed,
and omission is prevented. Given the lack of significant
contraindications in carbon nanoparticle tattooing method,
all patients with colorectal cancer could be implemented.
In addition, lesions could be found without any auxiliary
equipment during the intraoperative period. Owing to the
method of tattooing carbon nanoparticles, lesions in the
intraoperative period appeared clearer, and clinical experi-
ence showed that lesions still exist after more than
1.5 months. Compared with the control group, the lesions
in the experimental group were evidently manifested.
Meanwhile, the lesions of several patients in the control
group, which did not invade through the serosa, could not
be manifested visually and required intraoperative entero-
scopy to determine the location. Therefore, the time to de-
tect the tumor was greatly extended, and several obstacles
hindered the smooth progress of surgery. Moreover, the ex-
perimental group showed significantly shorter operation
time, more reduction in blood loss, more accurate resection
range, simpler method, and greater practicality than the
control group. As to postoperative complications, there
were no significant differences between the experimental
and the control groups.
Fig. 2 Positive lymph nodes. a Positive lymph nodes with carbon nanoparticles dyed. White arrow points to carbon nanoparticles dyestuff. Black
arrow points to the metastatic tumor cell clump. b Positive lymph nodes without carbon nanoparticles dyed. Black arrow points to the metastatic
tumor cell clump
Table 3 The relationship between clinical results and the time
of injection in patients using carbon nanoparticles
Variables The time of injection
(3–5 days) n = 17
The time of injection




3.06 ± 2.63 2.11 ± 0.44 0.269
Blood loss 123.24 ± 32.44 128.10 ± 24.97 0.687
Operation time 146.35 ± 32.19 159.50 ± 27.43 0.291
Dissected lymph
nodes number
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In terms of lymph node enhancement, carbon nanopar-
ticles can clearly show the distribution of lymph nodes.
Consistent with other studies [11], the average number of
dissected lymph nodes in the experimental group consid-
erably exceeded that in the control group. The rate of
dissected lymph node number ≥12 increased in the ex-
perimental group compared with that in the control
group. According to our experience, the method did not
affect the pathological diagnosis of lymph node. Increased
number of detected lymph nodes is associated with im-
proved survival rate [14, 15], and patients with ≥12 dis-
sected lymph node number presented higher overall 5-
year survival than those with <12 dissected lymph nodes
[16]. Therefore, lymph node tracing may contribute to
better prognosis. Although our study showed no statistical
difference in the rate of patients with lymph node metas-
tasis between the two groups (44.44 vs. 25.93 %, p =
0.154), the rate presented a tendency to reach a statistical
difference. In the process of pathological diagnosis, we
also found several black-stained particles (such as stained
lymph nodes). Paraffin section confirmed that several of
these particles were isolated tumor cells, which are report-
edly related to disease recurrence [35, 36]. Therefore,
carbon nanoparticles can contribute to the complete re-
moval of lymph nodes and isolated tumor cells to ac-
curately diagnose and improve survival rate.
The current study has several limitations. First, our
study is a single-center study involving a small sam-
ple and may not be applicable to the general popula-
tion. Second, our study did not analyze data from
long-term follow-up period, including disease recur-
rence and disease-free survival. Therefore, we cannot
directly determine the relationship between the use of
carbon nanoparticles and prognosis (Table 3). Third,
this is a case-control study in which some biases may
affect the outcomes. Large-sample, prospective, multi-
center studies, and further investigations with longer
duration are needed.
Conclusions
In conclusion, the findings of our study show that pre-
operative colonoscopic tattooing using carbon nanoparti-
cles is a safe and effective method that could be used for
tumor localization and lymph node tracing in laparoscopic
colorectal surgery. Therefore, we suggest that the carbon
nanoparticle tattooing method be performed in hospitals
that offer laparoscopic surgery. Reasonable and appropri-
ate application of carbon nanoparticles will facilitate the
marked development of the laparoscopic technique.
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